G01N 2333/5418
Il-7
G01N2333/5418 (Il-7) appears on 22 US grants and 39 published applications in this corpus.
Search patents in G01N- Granted patents
- 22
- Published applications
- 39
- Assignees
- 29
- Inventors
- 83
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 4 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 1 | 5 |
| 2018 | 1 | 3 |
| 2019 | 5 | 4 |
| 2020 | 2 | 2 |
| 2021 | 2 | 1 |
| 2022 | 1 | 2 |
| 2023 | 2 | 2 |
| 2024 | 0 | 4 |
| 2025 | 3 | 1 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Diagnostic methods for t cell therapy24 Feb 2026US 12,559,718 B2
- Methods of detecting and treating cerebral aneurysms17 Feb 2026US 12,553,904 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Methods of detecting septic arthritis, transient synovitis and osteomyelitis2 Sep 2025US 12,405,276 B2Washington University
- Il-7R-alpha specific antibodies for treating acute lymphoblastic leukemia29 Jul 2025US 12,371,500 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Antibodies directed against CD12729 Jul 2025US 12,371,502 B2Ose Immunotherapeutics
- Il-7r-alpha specific antibodies for treating acute lymphoblastic leukemia11 Jun 2026US 2026/0159595 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Methods of detecting and treating cerebral aneurysms19 Feb 2026US 2026/0049998 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Methods of detecting and treating cerebral aneurysms13 Nov 2025US 2025/0347700 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Blood Test to Screen Out Parkinson's Disease18 Jul 2024US 2024/0241138 A1University of North Texas Health Science Center at Fort Worth
- Precision Medicine Approach to Targeting Neurodegeneration16 May 2024US 2024/0159776 A1University of North Texas Health Science Center at Fort Worth
Most cited
By later US patents
- Human exhaled aerosol droplet biomarker system and method11US 9,617,582 B2University of Maryland, College Park · 2017
- Human exhaled aerosol droplet biomarker system and method6US 10,393,753 B2University of Maryland, College Park · 2019
- Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof5US 8,076,456 B2Intervet Inc. · 2011
- IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia4US 10,392,441 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2019
- Canine thymic stromal lymphopoietin protein and uses thereof to treat allergic symptoms4US 8,791,242 B2Intervet Inc. · 2014